Patients should be advised of the following:

* JE-VAX is given to provide immunization against Japanese encephalitis virus.

* A three-dose immunizing series should be completed, except in unusual circumstances. (See CONTRAINDICATIONS and DOSAGE AND ADMINISTRATION sections)

* JE-VAX should be given to a pregnant woman only if, in the opinion of a physician, withholding the vaccine entails even greater risk.

* Any adverse events following JE-VAX should be reported through the Vaccine Adverse Event Reporting System (VAERS) 1-800-822-7967 after contacting the physician immediately.

* If the patient has a past history of urticaria (hives) (following hymenoptera envenomation, drugs, physical or other provocation or of idiopathic origin), adverse effects are more likely.

* Adverse events consisting of arm soreness and local redness can occur shortly after vaccination.

* Adverse events consisting of headache, rash, edema and generalized urticaria or angioedema may occur shortly after vaccination or up to 17 days (usually within 10 days) following vaccination.

* International travel should not be initiated within 10 days of JE-VAX vaccination because of the possibility of delayed adverse reactions. Patients should be instructed to seek medical attention immediately upon onset of any adverse reaction.

* Personal precautions should be taken to avoid exposure to mosquito bites by the use of insect repellents, and protective clothing. Avoiding outdoor activity, especially during twilight periods and in the evening, will reduce risk even further.

Bookmark this page: